Skip to search.
 TSX Down 0.91% TSX Ventures Down 1.13%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
6.99 Down 0.14(1.96%) 11:39AM EDT - Nasdaq Real Time Price
Prev Close:7.13
Open:7.09
Bid:6.95 x 500
Ask:6.96 x 2000
1y Target Est:9.25
Beta:1.24953
Next Earnings Date: 5-May-16SPPI Earnings announcement
Day's Range:6.95 - 7.09
52wk Range:4.14 - 7.74
Volume:248,355
Avg Vol (3m):801,763
Market Cap:476.81M
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SPPIDown 1.96%476.81M
BIIBDown 3.03%58.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.86
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-16) :-1.37
Quarterly EPS Est (Mar-16) :-0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback